A detailed history of High Tower Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 64,728 shares of EXEL stock, worth $2.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,728
Previous 66,733 3.0%
Holding current value
$2.19 Million
Previous $1.5 Million 12.01%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.96 - $27.6 $44,029 - $55,338
-2,005 Reduced 3.0%
64,728 $1.68 Million
Q2 2024

Aug 13, 2024

SELL
$20.34 - $23.73 $201,772 - $235,401
-9,920 Reduced 12.94%
66,733 $1.5 Million
Q1 2024

May 06, 2024

SELL
$20.17 - $23.93 $393,375 - $466,706
-19,503 Reduced 20.28%
76,653 $1.82 Million
Q4 2023

Feb 12, 2024

BUY
$19.25 - $24.13 $630,976 - $790,933
32,778 Added 51.72%
96,156 $2.31 Million
Q3 2023

Nov 08, 2023

SELL
$19.04 - $22.74 $3,808 - $4,548
-200 Reduced 0.31%
63,378 $1.38 Million
Q2 2023

Aug 14, 2023

BUY
$18.17 - $20.48 $393,907 - $443,985
21,679 Added 51.74%
63,578 $1.21 Million
Q1 2023

May 11, 2023

BUY
$16.3 - $19.41 $27,465 - $32,705
1,685 Added 4.19%
41,899 $813,000
Q4 2022

Feb 08, 2023

BUY
$14.96 - $17.39 $116,493 - $135,415
7,787 Added 24.01%
40,214 $645,000
Q3 2022

Nov 09, 2022

BUY
$15.68 - $22.27 $33,414 - $47,457
2,131 Added 7.03%
32,427 $509,000
Q2 2022

Aug 10, 2022

BUY
$17.44 - $23.16 $17,265 - $22,928
990 Added 3.38%
30,296 $626,000
Q1 2022

May 12, 2022

SELL
$17.03 - $22.67 $57,237 - $76,193
-3,361 Reduced 10.29%
29,306 $663,000
Q4 2021

Feb 10, 2022

SELL
$15.84 - $21.88 $29,129 - $40,237
-1,839 Reduced 5.33%
32,667 $594,000
Q3 2021

Nov 12, 2021

SELL
$16.3 - $21.14 $2,852 - $3,699
-175 Reduced 0.5%
34,506 $727,000
Q2 2021

Aug 06, 2021

SELL
$17.95 - $25.56 $33,369 - $47,516
-1,859 Reduced 5.09%
34,681 $631,000
Q1 2021

May 10, 2021

SELL
$20.53 - $25.22 $20,961 - $25,749
-1,021 Reduced 2.72%
36,540 $825,000
Q4 2020

Feb 10, 2021

BUY
$18.39 - $24.8 $58,369 - $78,715
3,174 Added 9.23%
37,561 $754,000
Q3 2020

Nov 13, 2020

SELL
$20.67 - $26.94 $82,225 - $107,167
-3,978 Reduced 10.37%
34,387 $840,000
Q2 2020

Aug 10, 2020

BUY
$16.46 - $27.42 $5,398 - $8,993
328 Added 0.86%
38,365 $913,000
Q1 2020

May 21, 2020

BUY
$14.46 - $21.8 $3,542 - $5,341
245 Added 0.65%
38,037 $658,000
Q4 2019

Feb 14, 2020

SELL
$15.15 - $18.89 $41,874 - $52,211
-2,764 Reduced 6.82%
37,792 $667,000
Q3 2019

Nov 12, 2019

BUY
$17.68 - $22.65 $29,949 - $38,369
1,694 Added 4.36%
40,556 $718,000
Q2 2019

Aug 13, 2019

SELL
$18.93 - $24.75 $7,098 - $9,281
-375 Reduced 0.96%
38,862 $827,000
Q1 2019

May 15, 2019

BUY
$19.6 - $24.76 $22,069 - $27,879
1,126 Added 2.95%
39,237 $934,000
Q4 2018

Feb 14, 2019

SELL
$13.65 - $21.8 $2,375 - $3,793
-174 Reduced 0.45%
38,111 $749,000
Q3 2018

Nov 09, 2018

BUY
$15.87 - $22.4 $76,176 - $107,520
4,800 Added 14.33%
38,285 $682,000
Q2 2018

Aug 14, 2018

BUY
$18.56 - $22.45 $10,486 - $12,684
565 Added 1.72%
33,485 $722,000
Q1 2018

May 15, 2018

BUY
$22.15 - $31.89 $8,527 - $12,277
385 Added 1.18%
32,920 $726,000
Q4 2017

Feb 14, 2018

BUY
$24.23 - $30.93 $14,659 - $18,712
605 Added 1.89%
32,535 $988,000
Q3 2017

Nov 14, 2017

BUY
$23.35 - $29.24 $13,776 - $17,251
590 Added 1.88%
31,930 $773,000
Q2 2017

Aug 14, 2017

BUY
N/A
31,340
31,340 $772,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.